3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urologic Diseases
1
Nephritis
1
Lymphoma, Non-Hodgkin
1
Kidney Diseases
1
Immune System Diseases
1
Heart Failure
1
Glomerulonephritis, IGA
1
Glomerulonephritis
1
Cardiomyopathies
1
Autoimmune Diseases
1
Interventions
telitacicept
2
Prednisone
2
Blood Specimen Collection
2
thymoglobulin
1
remdesivir
1
prednylidene
1
fludarabine
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
apremilast
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Music Therapy
1
Methods
1
Melphalan
1
Mastectomy, Segmental
1
Mammaplasty
1
Interviews as Topic
1
Infliximab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Autoimmune Diseases
×
Valsartan
×
Clear all
NCT02765594
2017-09-20
HCQIgAN
Peking Union Medical College Hospital
Phase 4
Unknown
98 enrolled